4basebio PLC (4BB.L) LSE

785.00

+0(+0.00%)

Updated at November 07 02:55PM

Currency In GBp

Valuation

Market Cap158.71M
Enterprise Value139.32M
P/E Ratio-8.44
PEG Ratio1.62
Price/Sales Ratio68.33
Price/Book Ratio6.4
Enterprise/Revenue62.33
Enterprise/EBITDA-7.3

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-8.1
Operating Margin-10.73

Management Effectiveness

Return On Assets-0.39
Return On Equity-0.64

Income Statement

Revenue933,000
Revenue/Share0.11
Gross Profit630,000
EBITDA-10.97M
Net Income-12.33M
Diluted EPS-0.94

Balance Sheet

Total Cash26.11M
Total Cash/Share1.69
Total Debt15.44M
Total Debt/Equity0.81
Current Ratio11.36
Book Value Per Share1.23

Price History

52-Week Change-38.43
52-Week High1,500
52-Week Low700
Moving Average 50 Days789.8
Moving Average 200 Days995.78

Statistics

Average Volume1,256
Shares Outstanding15.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A